Beijing, China · Founded 2017 · Privately Held (backing)
Developer of oncology drugs intended to accelerate cancer drug discovery and development. KYinno Biotechnology is based in Beijing, China and was founded in 2017. Its last reported valuation was $68.3 million in Oct 2021. It has raised $59 million.
Last reported valuation
$68.3M
Oct 2026
Priced at
—
Total raised
$59.0M
Last round
—
Cap table — not yet on record
KYinno Biotechnology's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of KYinno Biotechnology with a free account
·Watch KYinno Biotechnology: the Monday email on marks, rounds and moves
